Epi proColon® 2.0 CE: A Blood-Based Screening Test for Colorectal Cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epi proColon® 2.0 CE: A Blood-Based Screening Test for Colorectal Cancer
Authors
Keywords
Colorectal Cancer, Colorectal Cancer Screening, Faecal Immunochemical Test, Colorectal Cancer Tissue, Sensitive Polymerase Chain Reaction
Journal
Molecular Diagnosis & Therapy
Volume 21, Issue 2, Pages 225-232
Publisher
Springer Nature
Online
2017-02-02
DOI
10.1007/s40291-017-0259-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection of Colorectal Cancer Using a Simplified SEPT9 Gene Methylation Assay Is a Reliable Method for Opportunistic Screening
- (2016) Dong Wu et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Stage at diagnosis and early mortality from cancer in England
- (2015) S McPhail et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm
- (2015) Peng Jin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany
- (2014) Andreas Adler et al. BMC GASTROENTEROLOGY
- Validation of a Real-Time PCR-Based Qualitative Assay for the Detection of Methylated SEPT9 DNA in Human Plasma
- (2014) N. T. Potter et al. CLINICAL CHEMISTRY
- An updated Asia Pacific Consensus Recommendations on colorectal cancer screening
- (2014) J J Y Sung et al. GUT
- Plasma Septin9 versus Fecal Immunochemical Testing for Colorectal Cancer Screening: A Prospective Multicenter Study
- (2014) David A. Johnson et al. PLoS One
- Detection of Methylated Septin 9 in Tissue and Plasma of Colorectal Patients with Neoplasia and the Relationship to the Amount of Circulating Cell-Free DNA
- (2014) Kinga Tóth et al. PLoS One
- Colorectal Cancer Screening with Blood-Based Biomarkers: Cost-Effectiveness of Methylated Septin 9 DNA versus Current Strategies
- (2013) U. Ladabaum et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Acute pancreatitis associated with a nontraumatic, intramural duodenal hematoma
- (2013) N. Veloso et al. ENDOSCOPY
- Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer
- (2013) Timothy Robert Church et al. GUT
- Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update
- (2013) M.J. Duffy et al. INTERNATIONAL JOURNAL OF CANCER
- Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers
- (2012) Kinga Tóth et al. PLoS One
- A comparison of qualitative and quantitative fecal immunochemical tests in the Korean national colorectal cancer screening program
- (2012) Mi Jin Park et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions
- (2010) Marc Tänzer et al. PLoS One
- Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
- (2009) T. deVos et al. CLINICAL CHEMISTRY
- Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
- (2008) Robert Grützmann et al. PLoS One
- DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
- (2007) C. Lofton-Day et al. CLINICAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started